AFT Pharmaceuticals - A strong start to FY20
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC...
731 Views
AFT Pharmaceuticals - Margins improving
AFT Pharmaceuticals recently reported its H119 results. Operating revenue grew 4.1% compared to H118 and was negatively affected by the divestment...
22 Views
AFT Pharmaceuticals - Improving profitability
AFT recently announced an agreement with Baxter Healthcare to divest to Baxter some of its non-core and low-margin hospital products in New...
48 Views
AFT Pharmaceuticals - Australia and Maxigesic driving growth
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC...
75 Views
On the cusp
AFT Pharma recently reported its FY17 results. Operating revenue grew 8.1% compared to FY16, mainly due to 19% growth in the Australian market,...
83 Views